New cancer drug GEN1056 tested for safety in advanced tumors
NCT ID NCT05586321
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 22 times
Summary
This early-stage study tested a new drug called GEN1056 in 26 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and find the best dose for future studies. All participants received GEN1056, and researchers monitored side effects and any signs of tumor shrinkage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ARENSIA Exploratory Medicine LLC
Tbilisi, Georgia
-
ARENSIA Exploratory Medicine Phase I Unit
Chisinau, Moldova
-
Centro Integral Oncologico Clara Campal
Madrid, Spain
-
Clinica Universidad de Navarra
Pamplona, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain
-
MD Anderson Cancer Centre
Madrid, Spain
Conditions
Explore the condition pages connected to this study.